Controlled trial of methotrexate versus 10-deazaaminopterin in the treatment of rheumatoid arthritis.
AUTOR(ES)
Alarcón, G S
RESUMO
A 15 week double blind controlled trial of methotrexate and 10-deazaaminopterin for the treatment of rheumatoid arthritis (RA) was performed in 26 patients. Significant improvement in all measured clinical parameters was observed in the two patient groups. The drugs were well tolerated; only one patient (10-deazaaminopterin) withdrew from the study because of side effects. It is concluded that, in the context of this relatively short clinical trial, 10-deazaaminopterin is at least as beneficial as methotrexate in the treatment of RA.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1005689Documentos Relacionados
- Controlled trial of penicillamine in severe rheumatoid arthritis.
- Methotrexate in rheumatoid arthritis.
- Indomethacin in the treatment of rheumatoid arthritis. A controlled trial comparing indomethacin, phenylbutazone, and placebo.
- Azathioprine: a controlled, double-blind trial in rheumatoid arthritis.
- Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis.
